Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Anticipated shortage | 2024-05-28 | 2024-05-28 | 229003 |
| LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2021-09-13 | 2024-05-29 | 145547 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-05-29 | 145541 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| MYLAN-LOSARTAN HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2017-07-17 | 2018-05-02 | 15956 |
| MYLAN-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2017-07-17 | 2018-05-02 | 15971 |
| MYLAN-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2017-07-17 | 2018-05-02 | 15953 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53201 |